???The mechanism of action of AZP-531 may lead to improved glycemia control in type 2 diabetes and also to positive effects on other cardiovascular risk factors, such as obesity, dyslipidemia and vascular complications,??? explained Professor AJ van der Lely, head of the clinical endocrinology at the Erasmus Medical Center in Rotterdam, the Netherlands, and scientific advisor at Alize Pharma. ???I